Healthcare of Ontario Pension Plan Trust Fund Acquires 17,539 Shares of Itron, Inc. (NASDAQ:ITRI)

Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Itron, Inc. (NASDAQ:ITRI) by 45.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 56,195 shares of the scientific and technical instruments company’s stock after acquiring an additional 17,539 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund owned 0.12% of Itron worth $4,243,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Natixis Advisors L.P. lifted its position in Itron by 0.4% in the 4th quarter. Natixis Advisors L.P. now owns 31,458 shares of the scientific and technical instruments company’s stock valued at $2,375,000 after acquiring an additional 139 shares in the last quarter. Advisors Asset Management Inc. lifted its position in Itron by 0.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 41,337 shares of the scientific and technical instruments company’s stock valued at $2,504,000 after acquiring an additional 180 shares in the last quarter. GAMMA Investing LLC bought a new position in Itron in the 4th quarter valued at approximately $27,000. Covestor Ltd lifted its position in Itron by 9,150.0% in the 3rd quarter. Covestor Ltd now owns 555 shares of the scientific and technical instruments company’s stock valued at $34,000 after acquiring an additional 549 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its position in Itron by 89.3% in the 4th quarter. Quadrant Capital Group LLC now owns 1,344 shares of the scientific and technical instruments company’s stock valued at $101,000 after acquiring an additional 634 shares in the last quarter. 96.19% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Itron news, SVP Christopher E. Ware sold 311 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $106.84, for a total value of $33,227.24. Following the completion of the sale, the senior vice president now owns 15,371 shares in the company, valued at approximately $1,642,237.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Itron news, SVP Christopher E. Ware sold 311 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $106.84, for a total value of $33,227.24. Following the completion of the sale, the senior vice president now owns 15,371 shares in the company, valued at approximately $1,642,237.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Thomas Deitrich sold 873 shares of the stock in a transaction on Friday, May 24th. The stock was sold at an average price of $108.87, for a total value of $95,043.51. Following the completion of the sale, the chief executive officer now owns 206,163 shares of the company’s stock, valued at approximately $22,444,965.81. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,775 shares of company stock worth $192,613. Corporate insiders own 1.45% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on ITRI shares. Oppenheimer upped their price objective on Itron from $100.00 to $110.00 and gave the company an “outperform” rating in a research report on Friday, May 3rd. Piper Sandler cut Itron from an “overweight” rating to a “neutral” rating and set a $109.00 price target on the stock. in a report on Tuesday, May 21st. Roth Mkm increased their price target on Itron from $102.00 to $112.00 and gave the company a “buy” rating in a report on Friday, May 3rd. Robert W. Baird increased their price target on Itron from $108.00 to $115.00 and gave the company an “outperform” rating in a report on Wednesday, March 13th. Finally, TheStreet raised Itron from a “c” rating to a “b-” rating in a report on Monday, February 26th. Five investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $104.18.

Itron Trading Down 0.1 %

NASDAQ:ITRI opened at $102.86 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.90 and a quick ratio of 1.40. The firm has a market capitalization of $4.72 billion, a price-to-earnings ratio of 29.56, a price-to-earnings-growth ratio of 1.02 and a beta of 1.47. Itron, Inc. has a one year low of $56.11 and a one year high of $111.00. The business has a fifty day moving average price of $102.49 and a 200-day moving average price of $87.70.

Itron (NASDAQ:ITRI) last issued its quarterly earnings results on Thursday, May 2nd. The scientific and technical instruments company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.85 by $0.39. Itron had a return on equity of 14.51% and a net margin of 7.03%. The business had revenue of $603.44 million during the quarter, compared to analyst estimates of $579.49 million. During the same quarter in the prior year, the business posted $0.49 EPS. Itron’s revenue for the quarter was up 22.0% compared to the same quarter last year. Sell-side analysts forecast that Itron, Inc. will post 4 EPS for the current year.

Itron Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.